Bioforce Nanosciences Holdings (BFNH) Notes Payables (2020 - 2022)

Bioforce Nanosciences Holdings (BFNH) has reported Notes Payables for 3 consecutive years, with $164681.0 the latest figure, recorded in Q3 2022.

• For the quarter ending Q3 2022, Notes Payables rose 33.52% year-over-year to $164681.0; the trailing twelve-month figure through Sep 2022 stood at $164681.0 (up 33.52% YoY), and the FY2021 full-year result was $116178.0, up 72.97% from the prior year.
• Notes Payables was $164681.0 for Q3 2022 at Bioforce Nanosciences Holdings, up from $156868.0 in the prior quarter.
• The five-year high for Notes Payables was $164681.0 in Q3 2022, with the low at $67166.0 in Q4 2020.
• Historically, Notes Payables has averaged $126022.9 across 3 years, with a median of $119756.5 in 2021.
• Annual changes were most pronounced in 2021 — Notes Payables surged 72.97% — and 2022, when it climbed 28.35%.
• Tracing BFNH's Notes Payables over 3 years: stood at $67166.0 in 2020, then surged by 72.97% to $116178.0 in 2021, then surged by 41.75% to $164681.0 in 2022.
• Per Business Quant data, the three most recent Notes Payables figures were $164681.0 in Q3 2022, $156868.0 in Q2 2022, and $149119.0 in Q1 2022.